Prevalence of sarcopenia in the world: A systematic review and meta- analysis of general population studies

被引：483
作者：
Shafiee G. [1 ]
Keshtkar A. [2 ]
Soltani A. [3 ]
Ahadi Z. [1 ]
Larijani B. [3 ]
Heshmat R. [1 ,4 ]
机构：
[1] Tehran University of Medical Sciences, Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran
[2] Tehran University of Medical Sciences, Department of Health Sciences Education Development, School of Public Health, Tehran
[3] Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran
[4] Endocrinology and Metabolism Research Center (EMRC), Dr Shariati Hospital, North Karegar St, Tehran
来源：
Journal of Diabetes & Metabolic Disorders | / 16卷 / 1期
关键词：
General population; Prevalence; Sarcopenia; Systematic review;
D O I：
10.1186/s40200-017-0302-x
中图分类号：
学科分类号：
摘要：
Background: Sarcopenia, an age-related decline in muscle mass and function, is one of the most important health problems in elderly with a high rate of adverse outcomes. However, several studies have investigated the prevalence of sarcopenia in the world, the results have been inconsistent. The current systematic review and meta- analysis study was conducted to estimate the overall prevalence of sarcopenia in both genders in different regions of the world. Methods: Electronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched between January 2009 and December 2016. The population- based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were selected. According to these consensual definitions, sarcopenia was defined by presence of low muscle mass (adjusted appendicular muscle mass for height) and muscle strength (handgrip strength) or physical performance (the usual gait speed). The random effect model was used for estimation the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia and 95% confidence interval (CI) were calculated using the Binomial Exact Method. Heterogeneity was assessed by subgroup analysis. Results: Thirty- five articles met our inclusion criteria, with a total of 58404 individuals. The overall estimates of prevalence was 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women, respectively. The prevalence was higher among non- Asian than Asian individuals in both genders especially, when the Bio-electrical Impedance Analysis (BIA) was used to measure muscle mass (19% vs 10% in men; 20% vs 11% in women). Conclusion: Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass and different regions of the world for estimating parameters of sarcopenia, present systematic review revealed that a substantial proportion of the old people has sarcopenia, even in healthy populations. However, sarcopenia is as a consequence of the aging progress, early diagnosis can prevent some adverse outcomes. © 2017 The Author(s).
引用
收藏
相关论文
共 58 条
[1]  
Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., Et al., Epidemiology of sarcopenia among the elderly in New Mexico, Am J Epidemiol, 147, 8, pp. 755-763, (1998)
[2]  
Lauretani F., Russo C.R., Bandinelli S., Bartali B., Cavazzini C., Iorio A., Et al., Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia, J Appl Physiol, 95, 5, pp. 1851-1860, (2003)
[3]  
Rizzoli R., Reginster J.Y., Arnal J.F., Bautmans I., Beaudart C., Bischoff-Ferrari H., Et al., Quality of life in sarcopenia and frailty, Calcif Tissue Int, 93, 2, pp. 101-120, (2013)
[4]  
Rantanen T., Muscle strength, disability and mortality, Scand J Med Sci Sports, 13, 1, pp. 3-8, (2003)
[5]  
Gallagher D., Visser M., Meersman R.E., Sepulveda D., Baumgartner R.N., Pierson R.N., Et al., Appendicular skeletal muscle mass: effects of age, gender, and ethnicity, J Appl Physiol, 83, 1, pp. 229-239, (1997)
[6]  
Pagotto V., Silveira E.A., Methods, diagnostic criteria, cutoff points, and prevalence of sarcopenia among older people, Scientific World Journal, 2014, (2014)
[7]  
Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Et al., Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people, Age Ageing, 39, 4, pp. 412-423, (2010)
[8]  
Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., Et al., Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia, J Am Med Dir Assoc, 12, 4, pp. 249-256, (2011)
[9]  
Chen L.K., Liu L.K., Woo J., Assantachai P., Auyeung T.W., Bahyah K.S., Et al., Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia, J Am Med Dir Assoc, 15, 2, pp. 95-101, (2014)
[10]  
Bischoff-Ferrari H.A., Orav J.E., Kanis J.A., Rizzoli R., Schlogl M., Staehelin H.B., Et al., Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older, Osteoporos Int, 26, 12, pp. 2793-2802, (2015)
123456